stars 1 stars 2 stars 3

Pharmapark is a privately-owned Russian biopharmaceutical company that is focused on development, manufacture and commercialization of biosimilar products. The company possesses the know-how and has a successful track record performing complete biotechnological drug development through commercial production. Pharmapark has successfully marketed 5 biosimilar products and has in-house pipeline of novel formulations and biosimilars focused on value-adding treatments.

Pharmapark Llc Questions

The Pharmapark Llc annual revenue was $5 million in 2026.

3 people are employed at Pharmapark Llc.

Pharmapark Llc is based in Krasnogorsk, Moscow Oblast.

The NAICS codes for Pharmapark Llc are [325, 3254, 32541, 32].

The SIC codes for Pharmapark Llc are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users